Skip to content

Effect of Mass Deworming on Child Growth

Increased Weight Gain in Preschool Children Due to Mass Albendazole Treatment Given During Child Health Days in Uganda

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00344669
Enrollment
10000
Registered
2006-06-27
Start date
2000-08-31
Completion date
2003-11-30
Last updated
2006-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Weight for Age in Preschool Children

Keywords

underweight, preschool, mass deworming

Brief summary

The purpose of the study was to determine whether periodical mass deworming improves growth in children below six years of age.

Detailed description

Many children in developing countries get slowed growth because of heavy loads of intestinal helminths. Quite often treatment is not sought because there may not be any obvious symptoms. Slowed growth may manifest as low weight for age or low height for age. The objective of the study was to estimate the effectiveness of the delivery of an anthelmintic drug through a community child health program on the weight gain of preschool aged children. Design: This was a cluster randomized controlled trial in 48 parishes in Eastern Uganda. All 48 parishes were participating in a new program for child health; 24 were randomly assigned to offer to children an additional service of anthelmintic treatment. The intervention was 400 mg of albendazole added to the standard services at child days over a 3 years period. All children were offered the drug and the main outcome measure was weight gain. Results: A total of 27,995 children were recruited into the 2 arms of the study with 14,940 in the treatment arm and 13,055 in the control arm. The intervention arm got an increase in weight gain of about 10% (166 grams per child per year (CI: 16-316) above expected weight gain when treatment was taken twice a year and an increase of 5% when treatment was received approximately annually. Conclusion: The inclusion of deworming in regularly scheduled health services appears practical and capable of increasing child growth.

Interventions

DRUGAlbendazole 400 mg, given 6 monthly

Sponsors

Ministry of Health, Uganda
CollaboratorOTHER_GOV
World Bank
CollaboratorOTHER
Makerere University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE

Eligibility

Sex/Gender
ALL
Age
1 Years to 7 Years
Healthy volunteers
No

Inclusion criteria

* children 1-6 years

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frame
weight gain
weight for age

Countries

Uganda

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026